Ari Shomair
Corporate Officer/Principal bei POINT Biopharma, Inc. (United States)
Aktive Positionen von Ari Shomair
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
POINT Biopharma, Inc. (United States)
POINT Biopharma, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Part of POINT Biopharma Global, Inc., POINT Biopharma, Inc. (United States) develops next-generation radioligand therapies for the treatment of cancer. The company is based in Indianapolis, IN. Joe McCann has been the CEO of the company since 2019. POINT Biopharma, Inc. (United States was acquired by Therapeutics Acquisition Corp. on June 30, 2021 for $578.95 million. | Corporate Officer/Principal | - | - |
Karriereverlauf von Ari Shomair
Ehemalige bekannte Positionen von Ari Shomair
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
POIT BIOP | Personalreferent | - | 27.12.2023 |
Public Communications Contact | - | - |
Statistik
International
Vereinigte Staaten | 3 |
Operativ
Human Resources Officer | 1 |
Public Communications Contact | 1 |
Corporate Officer/Principal | 1 |
Sektoral
Health Technology | 2 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
POIT BIOP | Health Technology |
Private Unternehmen | 1 |
---|---|
POINT Biopharma, Inc. (United States)
POINT Biopharma, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Part of POINT Biopharma Global, Inc., POINT Biopharma, Inc. (United States) develops next-generation radioligand therapies for the treatment of cancer. The company is based in Indianapolis, IN. Joe McCann has been the CEO of the company since 2019. POINT Biopharma, Inc. (United States was acquired by Therapeutics Acquisition Corp. on June 30, 2021 for $578.95 million. | Commercial Services |
- Börse
- Insiders
- Ari Shomair
- Erfahrung